课题基金 / 基金详情

COMBINATION ANTIRETROVIRAL THERAPY IN ADVANCED HIV DISEASE

COMBINATION ANTIRETROVIRAL THERAPY IN ADVANCED HIV DISEASE
晚期艾滋病毒的联合抗逆转录病毒治疗
批准号:
5220201
负责人:
RICHARD RUTSTEIN
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

RICHARD RUTSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a multicenter, outpatient, randomized, Phase I/II double-blind comparison of two double therapy regimens (zidovudine plus ddI and ddI plus nevirapine) and one triple therapy regimen (zidovudine, ddI, and nevirapine) in HIV-infected children and adolescents. This study is now closed to accrual after reaching the goal of 390 patients. We will continue to collect data from the study patients for the next 12 months. Data analysis is in progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF BMS-232632 IN COMBINATION REGIMENS IN ANTIRETROVIRAL THERAPY
  • 批准号:
    7207692
  • 项目类别:
  • 资助金额:
    $3.56万
  • 财政年份:
    2005
  • 负责人:
    RICHARD RUTSTEIN
  • 依托单位:
PACTG 326: ALVAC HIV VACCINES AND AIDSVAX B/B IN CHILDREN BORN TO HIV MOTHERS
  • 批准号:
    7207785
  • 项目类别:
  • 资助金额:
    $1.1万
  • 财政年份:
    2005
  • 负责人:
    RICHARD RUTSTEIN
  • 依托单位:
PACTG 326: ALVAC HIV VACCINES AND AIDSVAX B/B IN CHILDREN BORN TO HIV MOTHERS
  • 批准号:
    7041890
  • 项目类别:
  • 资助金额:
    $2.12万
  • 财政年份:
    2004
  • 负责人:
    RICHARD RUTSTEIN
  • 依托单位:
STUDY OF BMS-232632 IN COMBINATION REGIMENS IN ANTIRETROVIRAL THERAPY
  • 批准号:
    7041819
  • 项目类别:
  • 资助金额:
    $4.2万
  • 财政年份:
    2004
  • 负责人:
    RICHARD RUTSTEIN
  • 依托单位:
海外基金